isoxazoles has been researched along with dipyridamole in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alberti, D; Bruggink, J; Earhart, RH; Fischer, PH; Hamilton, RD; Koeller, JM; Simon, K; Tormey, DC; Tutsch, K; Willson, JK | 1 |
Bruggink, J; Fischer, PH; Ranhosky, A; Risueno, C; Trump, DL; Tutsch, K; Willson, JK | 1 |
Faderan, MA; Lui, MS; Natsumeda, Y; Weber, G | 1 |
Bittner, G; Fischer, PH; Pamukcu, R; Willson, JK | 1 |
Lui, MS; Weber, G; Zhen, YS | 1 |
Collins, M; Graves, LM; Huang, M; Wang, Y | 1 |
6 other study(ies) available for isoxazoles and dipyridamole
Article | Year |
---|---|
Phase I clinical trial of a combination of dipyridamole and acivicin based upon inhibition of nucleoside salvage.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; Dipyridamole; Drug Evaluation; Humans; Isoxazoles; Leukocyte Count; Metabolic Clearance Rate; Neoplasms; Nucleosides | 1988 |
Biochemical assessment of the effects of acivicin and dipyridamole given as a continuous 72-hour intravenous infusion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carbon-Nitrogen Ligases; Dipyridamole; Drug Evaluation; Humans; Infusions, Intravenous; Isoxazoles; Ligases; Nucleosides | 1988 |
Salvage capacity of hepatoma 3924A and action of dipyridamole.
Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Cells, Cultured; Dipyridamole; Drug Synergism; Guanine Deaminase; Hypoxanthine Phosphoribosyltransferase; Isoxazoles; Liver; Liver Neoplasms, Experimental; Pentosyltransferases; Purine Nucleotides; Pyrimidines; Rats; Xanthine Oxidase | 1983 |
Enhancement of the sensitivity of human colon cancer cells to growth inhibition by acivicin achieved through inhibition of nucleic acid precursor salvage by dipyridamole.
Topics: Antibiotics, Antineoplastic; Cell Cycle; Cell Line; Cell Survival; Colonic Neoplasms; Dipyridamole; Humans; Isoxazoles; Kinetics; Oxazoles; Ribonucleosides; Ribonucleotides | 1984 |
Effects of acivicin and dipyridamole on hepatoma 3924A cells.
Topics: Animals; Antimetabolites, Antineoplastic; Biological Transport; Deoxycytidine; Dipyridamole; Isoxazoles; Kinetics; Liver Neoplasms, Experimental; Oxazoles; Rats; Ribonucleosides | 1983 |
CPEC induces erythroid differentiation of human myeloid leukemia K562 cells through CTP depletion and p38 MAP kinase.
Topics: Affinity Labels; Carbon-Nitrogen Ligases; Cell Differentiation; Cytidine; Cytidine Triphosphate; Dipyridamole; Enzyme Inhibitors; Equilibrative Nucleoside Transporter 1; Erythroid Precursor Cells; Humans; Isoxazoles; K562 Cells; Leflunomide; Leukemia, Myeloid; p38 Mitogen-Activated Protein Kinases; Phosphodiesterase Inhibitors; Pyrimidines; RNA, Small Interfering; S Phase; Thioinosine | 2004 |